Evidence map›Paper›PMID 21325521›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

Functional nicotinic acetylcholine receptors containing α6 subunits are on GABAergic neuronal boutons adherent to ventral tegmental area dopamine neurons.

Kechun Yang, Lori Buhlman, Ghous M Khan, Robert A Nichols, Guozhang Jin, J Michael McIntosh, Paul Whiteaker, Ronald J Lukas, Jie Wu

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 83 citations in OpenAlex.

  1. "Unraveling the role ofReceptors (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Mechanisms of Nicotine Addiction.Cold Spring Harbor perspectives in medicine · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Mechanisms of cannabinoid CBEBioMedicine · 2019
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Kechun YangDivision of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013-4496, USA.
Lori Buhlman
Ghous M Khan
Robert A Nichols
Guozhang Jin
J Michael McIntosh
Paul Whiteaker
Ronald J Lukas
Jie Wu
Barrow Neurological Institute · USUniversity of Hawaiʻi at Mānoa · USNeurology, Inc · USShanghai Institute of Materia Medica · CNSt. Joseph's Hospital and Medical Center · USUniversity of Utah · US

Funding

Venoms, Biological Resources, Molecular BiologyP01GM048677 · NIGMS · UNIVERSITY OF UTAH · PI RIVIER, JEAN E · 1993 to 2018
$32.2M
Novel Neuronal nAChR-Targeted PeptidesR01MH053631 · NIMH · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2001 to 2011
$3.6M
ALPHA-CONOTOXIN MII--SELECTIVE NICOTINIC RECEPTOR PROBER01DA012242 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI WHITEAKER, PAUL · 1999 to 2011
$3.5M
Molecular Bases for Effects of NicotineR01DA015389 · NIDA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI LUKAS, RONALD J · 2003 to 2007
$1.6M
HOMOMERIC NICOTINIC ACETYLCHOLINE RECEPTORSR01NS040417 · NINDS · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI LUKAS, RONALD J · 2000 to 2002
$1.2M
Beta Amyloid and Presynaptic Nicotinic ReceptorsR01AG021586 · NIA · UNIVERSITY OF HAWAII AT MANOA · PI NICHOLS, ROBERT ALAN · 2004 to 2007
$887k
Construction and Expression of Concatemeric alpha6beta2* Nicotinic Acetycholine RR21DA026627 · NIDA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI WHITEAKER, PAUL · 2009 to 2010
$407k
NOVEL NEURONAL NACHR-TARGETED PEPTIDESR29MH053631 · NIMH · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 1996 to 2000
$107k
NIA NIH HHS AG021586NIA NIH HHS R01 AG021586NIDA NIH HHS DA012242NIDA NIH HHS DA015389NIDA NIH HHS R01 DA012242NIDA NIH HHS R01 DA015389NIDA NIH HHS R21 DA026627NIGMS NIH HHS GM048677NIGMS NIH HHS P01 GM048677NIMH NIH HHS MH053631NIMH NIH HHS R01 MH053631NIMH NIH HHS R29 MH053631NINDS NIH HHS NS040417NINDS NIH HHS R01 NS040417
6 · The paper itself

Abstract

Diverse nicotinic acetylcholine receptor (nAChR) subtypes containing different subunit combinations can be placed on nerve terminals or soma/dendrites in the ventral tegmental area (VTA). nAChR α6 subunit message is abundant in the VTA, but α6*-nAChR cellular localization, function, pharmacology, and roles in cholinergic modulation of dopaminergic (DA) neurons within the VTA are not well understood. Here, we report evidence for α6β2*-nAChR expression on GABA neuronal boutons terminating on VTA DA neurons. α-Conotoxin (α-Ctx) MII labeling coupled with immunocytochemical staining localizes putative α6*-nAChRs to presynaptic GABAergic boutons on acutely dissociated, rat VTA DA neurons. Functionally, acetylcholine (ACh) induces increases in the frequency of bicuculline-, picrotoxin-, and 4-aminopyridine-sensitive miniature IPSCs (mIPSCs) mediated by GABA(A) receptors. These increases are abolished by α6*-nAChR-selective α-Ctx MII or α-Ctx PIA (1 nm) but not by α7 (10 nm methyllycaconitine) or α4* (1 μm dihydro-β-erythroidine)-nAChR-selective antagonists. ACh also fails to increase mIPSC frequency in VTA DA neurons prepared from nAChR β2 knock-out mice. Moreover, ACh induces an α-Ctx PIA-sensitive elevation in intraterminal Ca(2+) in synaptosomes prepared from the rat VTA. Subchronic exposure to 500 nm nicotine reduces ACh-induced GABA release onto the VTA DA neurons, as does 10 d of systemic nicotine exposure. Collectively, these results indicate that α6β2*-nAChRs are located on presynaptic GABAergic boutons within the VTA and modulate GABA release onto DA neurons. These presynaptic α6β2*-nAChRs likely play important roles in nicotinic modulation of DA neuronal activity.

Indexed as

4-AminopyridineAcetylcholineAconitineAnimalsAnimals, NewbornBungarotoxinsCalciumConotoxinsDihydro-beta-ErythroidineDopamineDrug InteractionsExcitatory Amino Acid AgentsFemaleGABA Agentsgamma-Aminobutyric AcidGlutamate Decarboxylase4-AminopyridineAcetylcholineAconitineBungarotoxinsCalciumConotoxinsDihydro-beta-ErythroidineDopamineExcitatory Amino Acid AgentsGABA Agentsgamma-Aminobutyric AcidGlutamate Decarboxylaseglutamate decarboxylase 2methyllycaconitineNicotineNicotinic Antagonistsnicotinic receptor alpha6Potassium Channel BlockersReceptors, Nicotinic

Identifiers

PMID21325521
PMCPMC3081713
OpenAlexW1988072680

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.